The study, assessing pharmacokinetics, safety, and tolerability of AVT05 compared to Simponi® (golimumab) in healthy adult subjects, met its primary…
The study, assessing pharmacokinetics, safety, and tolerability of AVT05 compared to Simponi® (golimumab) in healthy adult subjects, met its primary…
Four cancer types now included in PeptiCRAd-1 with Pembrolizumab trial: sarcoma, melanoma, triple negative breast cancer and non-small cell lung…
Twenty-seven percent of workers prioritize wellbeing support over salary increase CHICAGO, Nov. 29, 2023 (GLOBE NEWSWIRE) -- TELUS Health today…
Cash balance of $16.4 million as at September 30, 2023Revenue of $1.0 million (vs 2022: $0.7 million, an increase of…
Repel and kill film formulation shows approximately 99.8% reduction in adhesion of bacteria to the surface and at least 99.6%…
STOCKHOLM, SE / ACCESSWIRE / November 29, 2023 / Promore Pharma (STO:PROMO)(FRA:8T0) Promore Pharma AB (publ) (the "Company" or "Promore")…
HALIFAX, NS / ACCESSWIRE / November 28, 2023 / MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for…
ISTANBUL, TURKEY / ACCESSWIRE / November 28, 2023 / Turkeyana Clinic, a premier healthcare provider known for its cutting-edge treatments…
VANCOUVER, BC / ACCESSWIRE / November 28, 2023 / 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF)(OTCQB:TGIFF), a Nevada-focused…